Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joseph C Sardano is CHIEF EXECUTIVE OFFICER at Sensus Healthcare. OQRO lists 2 transactions filed with the SEC under this name, the latest on Aug 24, 2026, each linked to the official Form 4.
CHIEF EXECUTIVE OFFICER
Disclosures on record
2
Companies involved
1
1 buy, median −7.2 pts vs S&P 500, beat it 0 of 1 time.
Average −7.2 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 19, 2025 to Nov 19, 2025, measured from the first close after the filing. Past results, not a forecast.
2 purchases disclosed; 0% of the 1 measured at 90 days finished ahead of the index. $1,000 placed after each of the 2 purchases disclosed since 2025-11-14 would be worth $1.3K today ($2K put in); the same in the S&P 500 (SPY): $2.1K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Sensus HealthcareSRTS
2 disclosures · Nov 2025 – Aug 2026 · 2 bought
Aug 20, 2026Bought~$60Kdisclosed Aug 24
DetailsOfficial recordNov 18, 2025Bought~$101Kdisclosed Nov 19
DetailsEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Joseph C Sardano bought shares on the open market in 2023, 2025 and 2026. Sales in 5 of the 11 years since 2016.
Joseph C Sardano reported 6 open-market purchases and 43 sales since 2016; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $60K1×1 trade | — |
| 2025 | $101K1×1 trade | — |
| 2023 | $142K4×4 trades | — |
| 2022 | — | $4.11M9×9 trades |
| 2021 | — | $553K6×6 trades |
| 2018 | — | $369K13×13 trades |
| 2017 | — | $323K11×11 trades |
| 2016 | — | $7.2K4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Joseph C Sardano reported holding 1,220,293 shares of Sensus Healthcare (SRTS), worth about $2.84M at the last close of $2 (Nov 13, 2026). In the last 12 months, Joseph C Sardano bought $161K in 2 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Sensus Healthcare SRTS | 1,220,293 | 1.22M direct | $2 | $2.84M | Aug 20, 2026 |
Is this Joseph C Sardano’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Aug 20, 2026, Joseph C Sardano reported holding 1,220,293 shares of Sensus Healthcare (SRTS). At the last close of $2 on Nov 13, 2026, that is about $2.84M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Joseph C Sardano reported 2 open-market purchases worth $161K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Joseph C Sardano bought shares on the open market in 2023, 2025 and 2026. Sales in 5 of the 11 years since 2016.
In SEC filings since 2016: the latest open-market purchase is from 2026; the latest open-market sale is from 2022.
Sensus Healthcare (SRTS), from 2016 to 2026: 6 purchases and 43 sales.
Joseph C Sardano reported 6 open-market purchases and 43 sales here, 2016 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.